US BANCORP \DE\ - APTEVO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$0208
-14.0%
0.00%
Q3 2019$02420.0%0.00%
Q2 2019$0242
-29.4%
0.00%
Q1 2019$0343
-2.6%
0.00%
Q4 2018$0
-100.0%
3520.0%0.00%
Q3 2018$2,0000.0%3520.0%0.00%
Q2 2018$2,000
-33.3%
352
-54.0%
0.00%
Q1 2018$3,000
-40.0%
765
-30.8%
0.00%
Q4 2017$5,000
+66.7%
1,105
-4.1%
0.00%
Q3 2017$3,0000.0%1,152
-21.8%
0.00%
Q2 2017$3,0000.0%1,473
-4.8%
0.00%
Q1 2017$3,000
-40.0%
1,548
-18.3%
0.00%
Q4 2016$5,000
-37.5%
1,895
-41.2%
0.00%
Q3 2016$8,0003,2210.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 1,021,836$1,298,0000.18%
HighVista Strategies LLC 79,568$101,0000.09%
ATLAS CAPITAL ADVISORS LLC 49,045$62,287,0000.02%
Spark Investment Management LLC 135,600$172,0000.01%
Park West Asset Management LLC 165,520$210,0000.01%
CSS LLC/IL 86,727$110,0000.01%
Meridian Wealth Advisors, LLC 5,000$6,0000.01%
ACADIAN ASSET MANAGEMENT LLC 462,824$587,0000.00%
OXFORD ASSET MANAGEMENT LLP 101,014$128,0000.00%
SFMG, LLC 15,544$20,0000.00%
View complete list of APTEVO THERAPEUTICS INC shareholders